TREATMENTS &
RESEARCH

Search the
latest
treatment
information
here.

Dr. Huntley's
Diagnosis
Checklist

Have a symptom?
See what questions
a doctor would ask.
 
Symptoms » Weakness » Book Sections
 

Hypotonia and Weakness

  • Hypotonia(decreased muscle tone) can be recognized by diminished resistanceto passive stretching of joints, by increased range of passive movement,and by the more "flappable" nature of an extremityin response to rapid movement.
  • Weakness (diminished muscle power)can be assessed by noting spontaneous motor activity and performanceof suspected muscle groups against gravity or other resistance.
  • Muscle power can be tested in olderchildren using the 6-point scale developed by Medical Research Council(Oppe, 1979):

  • 5is normal.
  • 4 is active movement against gravityand resistance simultaneously.
  • 3 is active movement against gravitybut not resistance.
  • 2 is active movement with gravity eliminatedby appropriate positioning of limb.
  • 1 is muscle contraction without jointmovement.
  • 0 is absence of any detectable musclecontraction.
  • Hypotonia and weakness are usuallycaused by disorders that affect brain, spinal cord, anterior horncell, peripheral nerve, neuromuscular junction, or muscle. Someconnective tissue and metabolic disorders also may cause hypotonia,usually without significant weakness.
  • Principal Causes of Hypotonia and Weakness

    1. Braindisorders
      1. Cerebralmalformations
      2. Chromosomal abnormalities
      3. Hypoxic-ischemic encephalopathy
      4. Hypotonic cerebral palsy
      5. Intracranial infection
      6. Trauma
      7. Metabolic disorders
      8. Neurodegenerative disorders
      9. Nonspecific mental retardation
    2. Spinal cord disorders
      1. Trauma
      2. Spinal dysraphism
      3. Neoplasm
    3. Anterior horn cell (or cranial motornuclei) disorders
      1. Spinal muscular atrophies
      2. Enteroviral infection
    4. Peripheral (or cranial) nerve disorders
      1. Acuteinflammatory demyelinating polyradiculopathy (Guillain-Barré syndrome)
      2. Chronic inflammatory demyelinatingpolyneuropathy
      3. Chronic motor-sensory polyneuropathy
      4. Sensory neuropathies
    5. Neuromuscular junction disorders
      1. Myasthenia
        1. Neonataltransient myasthenia gravis
        2. Congenital myasthenic syndromes
        3. Juvenile myasthenia gravis
      2. Botulism
      3. Tick paralysis
    6. Muscle disorders
      1. Congenitalmyopathies
        1. Centralcore disease
        2. Nemaline rod myopathy
        3. Myotubular myopathy
        4. Congenital myopathy with fiber-typedisproportion
        5. Other
      2. Metabolic myopathies
        1. Glycogenoses
          1. Glycogenstorage disease II
          2. Glycogen storage disease III
        2. Carnitine deficiency
          1. Medium-chainacyl-CoA dehydrogenase deficiency
          2. Primary carnitine deficiency (carnitinetransporter deficiency)
          3. Muscle carnitine deficiency
      3. Respiratory chain disorders
        1. Periodicparalysis
        2. Endocrine myopathies
      4. Dystrophies
        1. Congenital muscular dystrophy
        2. Duchenne muscular dystrophy
        3. Becker muscular dystrophy
        4. Emery-Dreifuss muscular dystrophy
        5. Limb-girdle muscular dystrophy
        6. Facioscapulohumeral muscular dystrophy
      5. Myotonic syndromes: myotonic dystrophy
      6. Inflammatory myopathies
        1. Dermatomyositis
        2. Polymyositis
    7. Connective tissue disorders
      1. Congenitallaxity of ligaments
      2. Ehlers-Danlos syndrome
      3. Marfan syndrome
    8. Metabolic disorders
      1. Hypopituitarism
      2. Renal tubular acidosis
      3. Rickets
      4. Hypercalcemia

    Clinical Features and Diagnosis

    Brain Disorders

    Cerebral Malformations

  • Lissencephaly(smooth brain) causes marked hypotonia in neonatal period followed byseizures and global developmental delay. MRI is procedure of choiceto demonstrate malformations (see Chap.40, Microcephaly).
  • Zellweger syndrome, a peroxisomal disorder,is characterized by pachygyria, polymicrogyria, severe hypotonia,neonatal seizures, hepatomegaly, leukodystrophy, renal cysts, andstippled calcification of patellae (see Chap. 13, Developmental Delay).
  • Dandy-Walker malformation, which consistsof posterior fossa cyst contiguous with fourth ventricle, partialor complete absence of cerebellar vermis, and hydrocephalus maybe associated with hypotonia in early infancy.
  • Chromosomal Abnormalities

  • Hypotoniaand delayed motor development are constant features of trisomy 21.Other chromosomal abnormalities that may be associated with hypotoniainclude trisomy 20p, 4p–, 9p–, and 18q– syndromes.Chromosomal karyotype confirms diagnosis.
  • Severe hypotonia, poor feeding, weakcry, and diminished deep tendon reflexes may occur in neonatal periodwith Prader Willi syndrome. Clinical manifestations that appearin childhood include hyperphagia, obesity, impaired linear growth,and diminished cognitive function (see Chap. 44, Obesity).
  • Hypoxic-Ischemic Encephalopathy

    Most common cause of hypotonia in newborns.May also occur after severe head trauma, intracranial hemorrhage,strangulation, suffocation, and near drowning.

    Hypotonic Cerebral Palsy

    May be suspected in children with historyof perinatal asphyxia or birth trauma. In many cases, cause is unknown.Clinical findings include hypotonia, delayed motor development,and sometimes athetosis and ataxia.

    Intracranial Infection

    Hypotonia may occur following bacterial meningitisor viral encephalitis (see Chap.3, Alteration in Consciousness).

    Trauma

  • Head traumamay cause cerebral contusion and intracranial hemorrhage, whichcan produce focal neurologic deficits, including seizures and hemiparesis.
  • CT or MRI can confirm diagnosis.
  • Metabolic Disorders

  • A numberof metabolic disorders can cause hypotonia without significant weakness, includingamino acid (nonketotic hyperglycinemia), organic acid (propionic,isovaleric, and methylmalonic acidemias), and lysosomal storage(mucopolysaccharidoses, lipidoses) disorders (see Chap. 3, Alteration in Consciousness,and Chap. 13, Developmental Delay).
  • Screening tests include serum electrolytes,glucose, ammonia, amino acids, lactate, pyruvate, carnitine; andurinary ketones, organic acids, and mucopolysaccharides.
  • Neurodegenerative Disorders

  • Degenerativedisorders of CNS that cause hypotonia include

  • Gray matter diseases (Tay-Sachs disease,Alpers disease, Menkes disease, GM-1 gangliosidosis, GM-2 gangliosidosis)
  • White matter diseases (Canavan disease,Pelizaeus-Merzbacher disease)
  • Diseases of gray and white matter (Zellwegersyndrome, neonatal adrenoleukodystrophy, Leigh syndrome)
  • See Chap.13, Developmental Delay.
  • Nonspecific Mental Retardation

    Hypotonia may be associated with nonspecificmental retardation. Other findings may include impaired or delayedmotor and language development.

    Spinal Cord Disorders

    Trauma

  • Spinal cordinjury secondary to trauma may cause hypotonia and weakness in acute phase.
  • Flaccid weakness occurs in lower extremitiesand sometimes upper extremities, depending on level of lesion. Deeptendon reflexes may be normal or hypoactive. Subsequently, hypotoniagives way to spasticity and tendon reflexes become hyperactive.
  • MRI is useful in defining locationand extent of injury.
  • Spinal Dysraphism

  • May be associatedwith hypotonia and weakness, usually of lower extremities.
  • Cutaneous dimples or tracts, subcutaneousmass, or abnormal collections of hair in spinal area should raisesuspicion of disorder of caudal neural tube formation. Sensory abnormalitiesof legs and feet and sphincter abnormalities also may be noted.
  • U/S may be performed initially.Combination of CT and MRI may be necessary for definitive diagnosis(see Chap. 69, Urinary Incontinence).
  • Neoplasm

    Tumors affecting spinal cord may cause spinalpain with radiation to specific dermatome, extremity weakness, impairedsensation, and lack of bowel and bladder control (see Chap. 5, Back Pain).

    Anterior Horn Cell Disorders

    Spinal Muscular Atrophies

  • Affect anteriorhorn cells of spinal cord and lower motor nuclei of brainstem. Genetic transmissionmay be autosomal recessive (most common), autosomal dominant, orX-linked.
  • 3 types of autosomal-recessive formshave been described. Genetic defect in these types involves q13region of chromosome 5.
  • Most severe is type I, with onset priorto 6 mos of age, failure to develop ability to sit, and death usuallyby 2 yrs of age. In type II, onset is before 18 mos of age, withfailure to develop ability to stand. Death occurs after 2 yrs ofage. Type III is defined by onset after 18 mos of age, with abilityto stand and usually walk, and death occurs in adulthood.
  • In type I, severe hypotonia and weaknessoccur, with legs more affected than arms, and proximal musculatureaffected more than distal.

  • Absence of deep tendon reflexes is almost alwaysfound.
  • Involvement of CN nuclei results indifficulty swallowing and weak cry.
  • Sensory and sphincter functions arenormal.
  • Muscle fasciculations may be seen,especially involving tongue.
  • Intelligence and language developmentare normal until regression begins to occur by about 1 yr of age.
  • Creatine phosphokinase (CPK) concentrationis normal.
  • U/S shows characteristic increasein intensity of echoes from muscle.
  • Fibrillation potentials may be seenwith electromyography. Motor nerve conduction velocities are normal.
  • Muscle biopsy shows characteristicdenervation pattern that helps confirm diagnosis. Molecular geneticanalysis is definitive.
  • Enteroviral Infection

  • Infectionwith enteroviruses can produce asymmetric weakness of limbs.
  • Prototype disease is poliomyelitis,but now only a few cases occur each year in the Western hemisphere,which are result of oral polio vaccine and not wild-type virus.Polioviruses (types 1, 2, 3) have predilection for anterior horncells of spinal cord and cranial nerve nuclei of brainstem.
  • Transmission is by fecal-oral route,with incubation period of 1–5 wks.
  • >90% of infectedchildren are asymptomatic or have mild nonparalytic disease.
  • Illness begins with URI or gastroenteritisfollowed within 1 wk by fever, headache, and muscle pain. Asymmetricextremity weakness (usually legs more than arms) and absence ofdeep tendon reflexes along with weakness of facial and pharyngealmuscles may occur.
  • Some children develop meningoencephalitiswith spinal fluid pleocytosis and increased protein concentration.
  • In most severe form, paralysis spreadsfrom legs to involve abdominal and thoracic musculature and arms.
  • Viral isolation from pharynx, stool,or spinal fluid is diagnostic. Specific polymerase chain reactiontests or paired serologic tests are also diagnostic.
  • Peripheral Nerve Disorders

    Acute Inflammatory Demyelinating Polyradiculopathy (Guillain-Barré Syndrome)

  • Prototypedisorder for acute diffuse peripheral neuropathy. Thought to haveautoimmune basis, perhaps triggered by viral infection.
  • In typical cases, symmetric weaknessascends from legs to trunk to arms and finally to bulbar muscles.In mild cases, only legs may be affected.
  • Weakness may evolve over a few daysto a few weeks. Sensory symptoms and signs are mild with pain andloss of vibratory or position sense in some patients.
  • Loss of pain and touch sensation areless common.
  • Involvement of cranial motor nerves,most commonly facial nerve, may produce difficulty with swallowingand speech.
  • Respiratory impairment with decreasedvital capacity and hypercarbia or frank respiratory failure arecommon complications.
  • Involvement of autonomic nerves cancause life-threatening cardiac arrhythmias or fluctuations in BP.
  • CSF is often normal in first few daysof illness; however, CSF protein increases during first 2 wks andpeaks by 4–5 wks into illness. CSF WBC count is usually <10cells/mm3 but may be up to 50cells/mm3.
  • Electromyographic findings are consistentwith neurogenic abnormalities. Motor nerve conduction velocity isusually decreased.
  • Diagnosis is based on above findings.
  • Chronic Inflammatory Demyelinating Polyneuropathy

  • Thoughtto be immune mediated, but inciting stimulus is unknown.
  • Duration is >2 mos.
  • Clinical features include distal extremityweakness and sensory loss leading to gait disturbance. Deep tendonreflexes are hypoactive or absent. Cranial nerve involvement andpain are uncommon.
  • CSF protein concentration is increased,but CSF WBC count is normal.
  • Motor nerve conduction velocity isslow.
  • Sural nerve biopsy may show demyelinization.
  • Chronic Motor-Sensory Polyneuropathy

  • Chronicmotor-sensory neuropathies may be inherited or acquired.
  • Hereditary motor-sensory neuropathiestypes I and II are characterized by extremity weakness, foot deformities(pes cavus and hammer toes), and variable loss of sensation. Onsetis usually in first or second decade.
  • Type III is characterized by onsetduring first year of life, with hypotonia and delay in developmentalmilestones. Muscle weakness (proximal and distal) and absence ofdeep tendon reflexes occur in childhood.
  • Many other hereditary motor-sensoryneuropathies also have been described (Swaiman and Ashwal, 1999).All may be distinguished by clinical, electromyographic, nerve biopsy,and molecular genetic analysis findings.
  • Peripheral neuropathy is also a featureof other genetic disorders, including metachromatic leukodystrophy,globoid cell leukodystrophy, and Friedreich ataxia (see Chap. 4, Ataxia, and Chap. 13, Developmental Delay).
  • Toxic neuropathies include lead poisoningand use of the chemotherapeutic agent vincristine.
  • Sensory Neuropathies

  • Includecongenital sensory neuropathy and familial dysautonomia and maypresent in infancy or childhood.
  • Characterized by hypotonia, impairedor absence of deep tendon reflexes, occasional limb weakness, andautonomic phenomena (e.g., decreased lacrimation). Impaired pain,touch, and temperature sensation also occur.
  • Motor nerve conduction velocities arenormal, whereas sensory nerve responses are impaired.
  • Sural nerve biopsy helps distinguishcongenital sensory neuropathy from familial dysautonomia (see Chap. 66, Sweating).
  • Neuromuscular Junction Disorders

    Myasthenia

  • Muscle weaknessstimulated by activity and relieved by rest characterizes myasthenia.
  • 3 types are neonatal transient myastheniagravis, congenital myasthenic syndromes, and juvenile myastheniagravis.
  • Neonatal Transient Myasthenia Gravis

  • Autoimmunedisorder that occurs in small number of infants born to motherswith myasthenia gravis.
  • Thought that passive transfer of antibodydirected against fetal acetylcholine receptor protein from motherleads to decrease in available acetylcholine receptors at postsynapticmembrane.
  • Onset in most infants is within 24hrs of birth.
  • Clinical manifestations include generalizedhypotonia and weakness, feeding and respiratory difficulty, facialweakness, and occasionally ptosis.
  • Administration of anticholinesteraseagent (e.g., edrophonium chloride, which results in decreased ptosis)is diagnostic. Finding increased serum concentration of acetylcholinereceptor binding antibody is also diagnostic.
  • Congenital Myasthenic Syndromes

  • Caused bygenetic defects affecting neuromuscular junction and not by autoimmune process.Mothers do not have myasthenia gravis.
  • Most common of these disorders wasformerly called congenital myasthenia but now is referred to asend-plate acetylcholine receptor deficiency.
  • Onset is usually in first weeks oflife with ptosis.
  • Ophthalmoplegia appears in ensuingmonths. Only after significant activity do hypotonia and weaknessoccur.
  • Diagnosis may be made by observingresponse to anticholinesterase drugs. Electrophysiologic and alpha-bungarotoxinbinding studies confirm deficiency in number or function of acetylcholine receptors.
  • Juvenile Myasthenia Gravis

  • Classicor juvenile form of myasthenia gravis occurs in children >2yrs of age; however, onset is usually in adolescence.
  • Most cases are caused by decrease innumber of available acetylcholine receptors secondary to circulatingreceptor-binding antibodies.
  • Usual finding at any age is weaknessthat worsens with exercise or repetitive use of muscles.
  • Diagnosis can be confirmed by detectionof antibodies against acetylcholine receptor protein or by pharmacologicor electrophysiologic means. Repetitive stimulation of motor nerveproduces progressive decrease in amplitude of action potential (decrementalconduction).
  • Botulism

  • Neurotoxinproduced by C. botulinum impairs release of acetylcholine from cholinergicnerve terminals.
  • Illness may be acquired by ingestionof food that was contaminated with toxin or improperly preserved(food borne), contamination of wound by clostridium organisms (woundbotulism), or production of C. botulinum toxin in intestine afterexposure to spores (infant botulism).
  • Infant botulism is much more commonthan foodborne or wound botulism.

  • Onset is usually at 2–4 mos of age,although it can occur in neonatal period.
  • Initially poor feeding, constipation,hypotonia, and weakness occur. Illness progresses with impairedsucking and swallowing and more severe weakness during next fewdays. Ptosis is common finding, but extraocular function is usuallyintact. Pupillary reactions to light are impaired or absent.
  • Characteristic electromyogram showsincremental response of muscle action potential with repetitivenerve stimulation and frequent, brief-duration, small-amplitudemotor unit potentials.
  • Diagnosis is confirmed by isolationof organism or detection of toxin in stool.
  • Tick Paralysis

  • Neurotoxinsproduced by dog tick (D. variabilis), which is found primarily insoutheastern U.S., and by wood tick (D. andersoni), which is foundprimarily in Rocky Mountain states, prevent release of acetylcholineat neuromuscular junction.
  • Tick exposure usually begins 5–10days before onset of illness, which is characterized by acute ascendingflaccid paralysis similar to that seen with Guillain-Barré syndrome.
  • Deep tendon reflexes are decreasedor absent, and sensation is intact.
  • Finding tick, which is often on scalp,is diagnostic. Removal results in dramatic improvement.
  • Muscle Disorders

    Primary clinical manifestation of muscledisease is weakness. Clinical presentation and course, mode of inheritance,muscle biopsy, and molecular genetic analysis help distinguish variousdisorders.

    Congenital Myopathies

    Central Core Disease

  • Onset ofthis autosomal-dominant disorder is in infancy or early childhood.
  • Gene locus has been mapped to chromosome19q13.1.
  • Usual presentation is hypotonia andweakness of proximal extremities (arms more than legs). Mild facialweakness also may occur.
  • Serum CPK is normal, and electromyographyusually shows myopathic pattern.
  • Muscle biopsy shows presence of coresof myofibrils undergoing degeneration in center of type I fibers.
  • Nemaline Rod Myopathy

  • 2 formshave been described.
  • In more common autosomal-dominant form,gene locus has been mapped to chromosome 1, and in autosomal-recessiveform, to chromosome 2.
  • Onset of autosomal-dominant form isin childhood, with slowly progressive generalized weakness, whereasonset of autosomal-recessive form is in neonatal period with respiratoryinsufficiency or in infancy with hypotonia and delayed motor development.
  • Muscle biopsy shows distinctive rodlikebodies in muscle fibers.
  • Myotubular Myopathy

  • Genetictransmission is usually X-linked; however, milder autosomal-dominantand -recessive forms also exist.
  • Onset is usually in infancy, with generalizedhypotonia and weakness. Other findings include facial weakness,ptosis, and impaired extraocular movements.
  • Distinctive muscle biopsy shows musclefibers that resemble fetal myotubes.
  • Congenital Myopathy with Fiber-Type Disproportion

  • Genetictransmission may be autosomal dominant or autosomal recessive.
  • Onset is in infancy, with hypotoniaand weakness (proximal more than distal muscles). Facial weakness,congenital hip dislocation, and joint contractures also may occur.
  • Muscle biopsy shows predominance ofsmall type I fibers and compensatory hypertrophy of type II fibers.
  • Other

    Several unusual congenital myopathies havebeen described with distinctive morphologic changes on muscle biopsy:fingerprint bodies, spheroid bodies, cytoplasmic bodies, sarcoplasmicbodies, zebra bodies, minicores, and Mallory body–likeinclusions.

    Metabolic Myopathies

    Glycogenoses

    Glycogen Storage Disease Type II

  • Autosomal-recessivedisorder caused by deficiency of acid alpha-1,4-glucosidase (acidmaltase). Gene locus has been mapped to chromosome 17q25.2-q25.3.
  • Classic form (Pompe disease) presentsin infancy with severe hypotonia and weakness as well as difficultyin sucking and swallowing. Tongue is usually enlarged and may havefasciculations. Enlarged liver and cardiomyopathy are other usualfindings. Death usually occurs before 2 yrs of age.
  • Milder form may present in older childrenwith primarily skeletal muscle involvement.
  • Diagnosis may be confirmed by enzymeassay of muscle, or cultured fibroblasts, or by molecular geneticanalysis.
  • Glycogen Storage Disease Type III

  • Deficiencyof glycogen debrancher enzyme occurs in this autosomal-recessivedisorder. Gene locus has been mapped to chromosome 1p21. Involvementof both liver and muscle (type IIIa) is found in most affected individuals,whereas some have only liver involvement (type IIIb).
  • Characteristic findings include hypotonia,weakness, hepatomegaly, poor growth, hypoglycemia, and hyperlipidemia.
  • Enzyme assay of liver and muscle tissueconfirms diagnosis.
  • Carnitine Deficiency

    Carnitine, produced almost exclusively inliver, is indispensable carrier of fatty acids into mitochondria,where they undergo beta oxidation. Most cases have been shown tobe due to defects in fatty acid oxidation; most common is medium-chainacyl-CoA dehydrogenase deficiency. 2 other disorders of carnitinemetabolism have been associated with decrease in carnitine concentrationin muscle: primary carnitine deficiency (carnitine transporter deficiency)and muscle carnitine deficiency.

    Medium-Chain Acyl-CoA Dehydrogenase Deficiency

  • Autosomal-recessivedisorder caused by mutations in medium-chain acyl-CoA dehydrogenasegene, whose locus has been mapped to chromosome 1p31.
  • Presenting features are poor feeding,respiratory distress, hypotonia, and alteration in consciousness.
  • Lab findings include hypoglycemia withoutketones, metabolic acidosis, hyperammonemia, low serum carnitine,and dicarboxylic aciduria.
  • Assay of plasma acylcarnitines is diagnostic.Demonstration of enzyme defect in leukocytes or fibroblasts is definitive.
  • Primary Carnitine Deficiency (Carnitine Transporter Deficiency)

  • Caused bymutations in SLC22A5 gene on chromosome 5. This gene encodes sodium ion-dependentcarnitine transporter OCTN2.
  • Onset is usually in infancy or earlychildhood, with hypotonia and weakness. These individuals tend todevelop hypoglycemic coma precipitated by prolonged fasting.
  • Serum, muscle, and liver carnitineconcentrations are low.
  • Muscle Carnitine Deficiency

  • Autosomal-recessivedisorder that involves deficient transport of carnitine across intestinalmucosa.
  • Onset is usually in late childhoodor adolescence with generalized proximal muscle weakness.
  • Muscle biopsy reveals lipid storagemainly in type I fibers and low carnitine concentration in muscle.Serum carnitine concentration is normal.
  • Respiratory Chain Disorders

  • Includedefects in complex I, complex III, complex IV, and multiple enzymesof respiratory chain (mitochondrial DNA depletion).
  • Marked hypotonia and weakness may occurin neonatal period. Hepatomegaly and cardiomyopathy also may occur.Defects in complexes I, III, and IV also can present primarily asencephalopathy.
  • Abnormal serum lactate/pyruvateratio (>20) suggests respiratory chain disorder.
  • Muscle biopsy including electron microscopyand respiratory chain enzyme analysis is diagnostic.
  • Periodic Paralysis

  • 3 typesof familial (genetic) periodic paralysis are hypokalemic, hyperkalemic,and normokalemic. Genetic transmission of each disorder is autosomal-dominant.
  • Hypokalemic periodic paralysis usuallypresents in childhood or adolescence with episodic weakness andlow serum potassium levels. Episodes may be precipitated by restafter exercise, meal high in carbohydrate content, exposure to cold,and physical or emotional stress. Gene locus has been mapped tochromosome 1q31-32.
  • Hyperkalemic periodic paralysis ismore likely to occur in infancy and childhood. Onset of episodicweakness usually occurs after exercise. Serum potassium concentrationis increased during an episode. Gene locus has been mapped to chromosome17q23.1-q25.3.
  • Normokalemic periodic paralysis isclinically similar to hyperkalemic form, but serum potassium concentrationis normal during an episode.
  • Endocrine Myopathies

    Proximal extremity weakness (legs more thanarms) that is progressive can be caused by hyperthyroidism, hypothyroidism,hyperadrenalism, hypoadrenalism, hyperparathyroidism, and hypoparathyroidism.See other chapters for discussion of some of these disorders.

    Dystrophies

    Group of genetically transmitted muscle disorderscharacterized by progressive degeneration of skeletal muscle.

    Congenital Muscular Dystrophy

  • Encompassesseveral disorders that are characterized by generalized hypotoniaand weakness and early joint contractures. Disorders can be classifiedaccording to presence of muscle involvement (merosin-positive congenitalmuscular dystrophy) or both muscle and CNS involvement [congenitalmuscular dystrophy with white matter abnormality (merosin-deficienttype), Fukuyama congenital muscular dystrophy, muscle-eye-braindisease, and Walker-Warburg syndrome].
  • Lab tests usually reveal increasedserum CPK, nonspecific myopathic pattern with electromyography,and dystrophic changes on muscle biopsy.
  • MRI demonstrates brain abnormalities.
  • Duchenne Muscular Dystrophy

  • This X-linkeddisorder is most common type of muscular dystrophy in childhood.
  • Caused by mutations in gene that encodesprotein dystrophin.
  • Onset is usually at 2–4 yrsof age with progressive muscle weakness, lumbar lordosis, calf musclepseudohypertrophy, and positive Gower sign. Cardiomyopathy and impairedintellectual ability also may occur.
  • Lab tests reveal very high serum CPK,increase in echoes of involved muscle on U/S, myopathicchanges on electromyography, and myofiber degeneration and connectivetissue proliferation on muscle biopsy.
  • Molecular genetic analysis is now standardfor diagnosis.
  • Becker Muscular Dystrophy

  • Same geneis defective in Becker muscular dystrophy as in Duchenne musculardystrophy, but in Becker muscular dystrophy onset is later in childhood(after 5 yrs of age), clinical course is milder, and progressionis slower.
  • Dystrophin analysis of muscle can distinguishDuchenne muscular dystrophy from Becker muscular dystrophy. In theformer, dystrophin content is <3% of normal, whereasin the latter, it is 3–20% of normal.
  • Emery-Dreifuss Muscular Dystrophy

  • 2 typeshave been described. Type 1 is X-linked and caused by mutationsin gene that encodes the protein emerin, while type 2 is autosomal-dominantwith mutations in gene on chromosome 1q21.2 that encodes the proteinlamin A/C.
  • Both types have same clinical phenotypewith onset at 5–15 yrs of age.
  • Characteristic features include weakness,primarily in legs and shoulder girdle, cardiomyopathy, and normalintellectual function.
  • Serum CPK is mildly increased.
  • Molecular genetic analysis is definitive.
  • Limb-Girdle Muscular Dystrophy

  • Onset isin childhood or adolescence, with weakness of hip and shoulder girdlemuscles.
  • Later in the course, distal musclesbecome weak. Facial weakness may or may not occur.
  • Autosomal-dominant, autosomal-recessive,and X-linked transmission may occur depending on specific disorder.
  • Molecular genetic analysis is definitive.
  • Facioscapulohumeral Muscular Dystrophy

  • Autosomal-dominantdisorder associated with deletion at chromosome 4q35 locus.
  • Onset is variable but typically occursin second decade of life with weakness of facial, shoulder, andupper arm muscles. Foot extensor and pelvic girdle muscle weaknessmay also occur.
  • Serum CPK may be normal or increased.
  • Molecular genetic analysis is confirmatory.
  • Myotonic Syndromes: Myotonic Dystrophy

  • Autosomal-dominantdisorder almost always transmitted by affected mother. Abnormalgene has been mapped to chromosome 19q13 in most common form.
  • Mother usually has signs of myotonicdystrophy—long immobile face due to atrophy of temporalisand masseter muscles, ptosis, and myotonia (inability to open eyesfor a few seconds after closing them tightly and failure of immediateextension of fingers after forming clenched fist).
  • Usual findings in affected infant duringfirst days of life are hypotonia, bilateral facial weakness, poorfeeding, and respiratory difficulty.
  • Clinical findings of infant and motherand characteristic electromyogram in mother (motor unit potentialsthat wax and wane in amplitude and frequency indicative of myotonia)confirm diagnosis.
  • Beyond neonatal period, onset is usuallyduring adolescence or later.

  • Characterized by distal muscle weakness, especiallyof intrinsic muscles of hands, facial weakness with muscle atrophy,and myotonia (usually present after 5 yrs of age). Weakness is slowly progressiveand eventually involves proximal musculature.
  • Serum CPK is normal or mildly increased.Clinical features, family history, and characteristic electromyogramare diagnostic.
  • Molecular genetic analysis is definitive.
  • Inflammatory Myopathies

    Dermatomyositis

  • This formof connective tissue disease has 3 main features: muscle weakness,skin lesions, and systemic symptoms (e.g., malaise and fatigue).
  • Usually occurs in school age children.
  • Weakness is usually proximal and symmetricand begins in legs, but some children have generalized weakness.Erythematous discoloration may be found over upper eyelids, nose,cheek, and joints (metacarpophalangeal, interphalangeal, elbow,knee). Gottron nodules also may be seen over finger joints. Othermanifestations include fever, swallowing difficulty, hepatosplenomegaly,lymphadenopathy, and calcinosis of muscle or skin.
  • Muscle biopsy helps confirm diagnosis.
  • Polymyositis

  • Producessymmetric weakness of proximal limb and trunk muscles without skinlesions but is uncommon in children.
  • Onset is usually insidious but progressiveover weeks or months.
  • Febrile illness occasionally precedesmuscle weakness.
  • Serum concentrations of muscle enzymes(creatine phosphokinase, aldolase, aspartate aminotransferase) areusually increased.
  • Muscle biopsy confirms diagnosis.
  • Connective Tissue Disorders

    Congenital Laxity of Ligaments

  • Individualshave hypotonia and increased joint mobility but normal muscle strength andpreserved deep tendon reflexes.
  • Criteria of joint laxity and hypermobilityare hyperextension of knees and elbows beyond 180 degrees, increasedhip abduction (usually to 90 degrees), hyperextension of metacarpophalangeal jointsof fingers with extension of wrist to 90 degrees, approximationof thumb to anterior aspect of forearm, and dorsiflexion of anklesbeyond 45 degrees from neutral position.
  • Congenital dislocation of hip and scoliosismay be associated findings.
  • Ehlers-Danlos Syndrome

    Primary manifestations are fragile, easilybruised, stretched skin, and hyperextensible joints. See Chap. 52, Purpura and Bleeding.

    Marfan Syndrome

    Easily stretched skin, hypermobile joints,long thin extremities and fingers, dislocated lens, and aortic incompetencecharacterize Marfan syndrome, an autosomal-dominant disorder. See Chap. 68, Tall Stature.

    Metabolic Disorders

    Hypotonia also may occur with hypopituitarism,renal tubular acidosis, rickets, and hypercalcemia. See discussionof some of these disorders in other chapters.

    Diagnostic Approach

  • First stepis to determine whether disorder involves nervous system includingneuromuscular system. This can usually be accomplished by historyand physical exam.
  • If disorder involves nervous system,next step is to define anatomic level of abnormality—brain,spinal cord, anterior horn cell, peripheral nerve, neuromuscularjunction, or muscle. This can usually be accomplished by consideringdistinguishing features (e.g., pattern of weakness, deep tendonreflexes, presence of sensory loss or fasciculations, serum muscleenzyme levels, CSF findings, electromyographic pattern, nerve conductionvelocities, and muscle biopsy).
  • Final step is to make specific diagnosis,which usually can be done by analysis of the above findings, otherclinical findings, and other investigations.
  • Brain

  • Characteristicfindings with brain disorders include weakness of extremities (proximalas much as or more than distal), normal or increased deep tendonreflexes, seizures, developmental delay, and cognitive change.
  • Degree of weakness is usually lessstriking than degree of hypotonia. Cranial nerve nuclei also maybe involved.
  • Serum muscle enzymes, electromyography,and muscle biopsy are normal, except for particular disorders (e.g.,congenital muscle dystrophies) in which muscle and brain may beabnormal.
  • Neuroimaging is useful in diagnosisof many of these disorders.
  • Spinal Cord

  • Disordersaffecting spinal cord may produce flaccid weakness of all extremitiesif injury involves cervical region; usually normal or hypoactivedeep tendon reflexes, which can become hyperactive in next few weeksor months; sphincter abnormalities; and sensory level on trunk.
  • Cranial nerve function is normal.
  • MRI is useful in defining locationand extent of spinal cord lesion.
  • Anterior Horn Cell

  • Characteristicfindings of spinal muscular atrophies include severe hypotonia and weakness(proximal as much as or more than distal), muscle fasciculations,and absence of deep tendon reflexes. Facial weakness also may occur.Sensory function, spinal fluid analysis, and serum muscle enzymelevels are normal.
  • Fibrillations can be demonstrated byelectromyography.
  • Muscle biopsy shows denervation patternin which hallmark is atrophy of group of muscle fibers. Enteroviralinfection affecting anterior horn cells commonly produces asymmetricweakness and abnormal spinal fluid.
  • Peripheral Nerve

  • Characterizedby marked weakness (usually distal more than proximal), decreasedor absent deep tendon reflexes, abnormal sensory examination, increasedcerebrospinal fluid protein concentration, and decreased nerve conductionvelocities.
  • Muscle biopsy shows denervation pattern,and nerve biopsy is usually abnormal.
  • Neuromuscular Junction

  • Disordersof neuromuscular junction produce generalized weakness (proximalas much as distal). Facial weakness is usual finding, and extraocularmuscles may be involved. Deep tendon reflexes are usually normal.Sensory function, spinal fluid analysis, serum muscle enzyme levels,and muscle biopsy are normal.
  • Electromyography shows characteristicdecremental response to repetitive stimulation with myasthenia gravis.There is usually positive response to neostigmine or edrophonium.
  • Typical electromyographic findingsin botulism are incremental response with repetitive stimulationand frequent, brief duration, small amplitude motor unit potentials.Pupillary responses to light are impaired or absent with botulism.
  • Muscle

  • Muscle disordersproduce weakness, with proximal weakness often more pronounced thandistal weakness. Facial weakness is variable but may occur withseveral muscle disorders. These include central core disease, myotubularmyopathy, nemaline myopathy, congenital fiber disproportion, congenitalmuscular dystrophy, facioscapulohumeral dystrophy, and myotonicdystrophy. Deep tendon reflexes are usually decreased in proportionto weakness.
  • Sensory function and spinal fluid analysisare normal. Increased serum concentration of muscle enzymes is variable.
  • Electromyography shows small-amplitude,short-duration motor unit potentials and myopathic polyphasic potentials.
  • Muscle biopsy shows myopathic pattern,and nongrouped atrophy is essential feature.
  • Various studies of muscle (histologic,histochemical, biochemical, immunocytochemical, electron microscopic)are often needed for diagnosis.
  • Molecular genetic analysis can nowbe performed for definitive diagnosis of many muscle disorders.
  • References

    1. Behrman RE, et al., eds. Nelson textbookof pediatrics, 16th ed. Philadelphia: WB Saunders, 2000.
    2. Dubowitz V. Muscle disorders in childhood, 2nd ed.London: WB Saunders, 1995.
    3. Fenichel GM. Clinical pediatric neurology: a signsand symptoms approach, 4th ed. Philadelphia: WB Saunders, 2001.
    4. Jones KL. Smith's recognizable patterns ofhuman malformation, 5th ed. Philadelphia: WB Saunders, 1997.
    5. Long SS, et al., eds. Principles and practice of pediatricinfectious diseases. New York: Churchill Livingstone, 1997.
    6. Online Mendelian Inheritance in Man (OMIM). McKusick-NathansInstitute for Genetic Medicine, Johns Hopkins University (Baltimore,MD) and National Center for Biotechnology Information, NationalLibrary of Medicine (Bethesda, MD), 2000. World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim.
    7. Oppe TE. Neurological examination. In: Rose FC, ed.Pediatric neurology. Oxford: Blackwell Scientific, 1979:1–17.
    8. Rudolph AM, ed. Rudolph's pediatrics, 20thed. Stamford, CT: Appleton & Lange, 1996.
    9. Scriver CR, et al., eds. The metabolic and molecularbases of inherited disease, 8th ed. New York: McGraw-Hill, 2001.
    10. Swaiman KF, Ashwal S, eds. Pediatric neurology: principles & practice,3rd ed. St. Louis: CV Mosby, 1999.
    11. Volpe JJ. Neurology of the newborn, 4th ed. Philadelphia:WB Saunders, 2001.
    >>

    Book Source Details

    • Book Title: The Diagnostic Approach to Symptoms and Signs in Pediatrics
    • Author(s): Paul S. Bellet
    • Year of Publication: 2006
    • Copyright Details: The Diagnostic Approach to Symptoms and Signs in Pediatrics, Copyright © 2006 Lippincott Williams & Wilkins.

    Other Book Chapters Related to Weakness

    Read excerpts from these other book chapters related to Weakness:

    Medical Books Excerpts
    • FATIGUE
    • "Algorithmic Diagnosis of Symptoms and Signs" (2003)
    • Fatigue
    • "In a Page: Signs and Symptoms" (2004)
    • Fatigue
    • "In A Page: Pediatric Signs and Symptoms" (2007)
    • Fatigue
    • "Handbook of Signs & Symptoms (Third Edition)" (2006)
    • Paralysis
    • "Handbook of Signs & Symptoms (Third Edition)" (2006)
    • Fatigue
    • "Professional Guide to Signs & Symptoms (Fifth Edition)" (2006)
    • Paralysis
    • "Professional Guide to Signs & Symptoms (Fifth Edition)" (2006)
    • Fatigue
    • "The 10-Minute Diagnosis Manual: Symptoms and Signs in the Time-Limited Encounter" (2000)
    • Fatigue
    • "Field Guide to Bedside Diagnosis" (2007)
    • Paralysis
    • "Alarming Signs and Symptoms: Lippincott Manual of Nursing Practice Series" (2007)
    • Fatigue
    • "Signs & Symptoms: A 2-in-1 Reference for Nurses" (2007)
    • Paralysis
    • "Signs & Symptoms: A 2-in-1 Reference for Nurses" (2007)
    • Fatigue
    • "The Diagnostic Approach to Symptoms and Signs in Pediatrics" (2006)
    • Fatigue
    • "Nursing: Interpreting Signs and Symptoms" (2007)
    • Paralysis
    • "Nursing: Interpreting Signs and Symptoms" (2007)
     

    Copyright Details: The Diagnostic Approach to Symptoms and Signs in Pediatrics, Copyright © 2008 Williams & Wilkins.

    More About Causes of Weakness




    More About This Book:
    Title: The Diagnostic Approach to Symptoms and Signs in Pediatrics
    Authors: Paul S. Bellet
    Publisher: Lippincott Williams & Wilkins
    Copyright: 2006
    ISBN: 0-78172-899-1

     » Next page: Muscle weakness (Nursing: Interpreting Signs and Symptoms)

    Rate This Website

    What do you think about the features of this website? Take our user survey and have your say:

    Website User Survey

    Medical Tools & Articles:

    Next articles:

    Tools & Services:

    Medical Articles:

    Forums & Message Boards

     
    HONcode We subscribe to the HONcode principles

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise